Kanoria Chemicals FY26: Revenue Up 29%, EBITDA Soars 52% to ₹815.8 Crore

Kanoria Chemicals & Industries Limited announced its financial results for the fiscal year 2025-26, presenting a significantly improved performance compared to the previous year. The company reported an increase in Operating Revenue by 29% to ₹87,534 lakhs and a substantial 52% rise in EBITDA to ₹8,158 lakhs.

EBITDA margins improved to 9.3% from 7.9% in FY2025. The company also saw a 66% increase in EBTDA, which represents the cash profit. An exceptional item of ₹1,064 lakhs was recorded as a non-cash impairment loss on investments in APAG Holding AG, previously a subsidiary. Additionally, a negative tax of ₹2,143 lakhs resulted from the reversal of Deferred Tax due to the transition to a new tax regime.

Consolidated figures show Operating Revenue at ₹98,143 lakhs, up 30% from FY2025. Consolidated EBITDA surged by 90% to ₹9,379 lakhs, with consolidated EBTDA improving to ₹6,182 lakhs from ₹1,830 lakhs. Net Profit for the consolidated entity stood at ₹11,319 lakhs, a significant turnaround from a loss of ₹10,815 lakhs in the previous fiscal year. The company's Earnings Per Share (EPS) improved to ₹27.64 from a negative ₹19.13.

The company has outlined its 'Vision 2030' roadmap for sustainable growth and improved profitability. Favorable business prospects are anticipated due to increasing industrial activity and growing customer demand. Projects for diversification into speciality chemicals, Triacetin and Penta Derivatives, are expected to be commissioned shortly. Kanoria Chemicals is also actively pursuing capacity expansion in Formaldehyde and Resin, alongside continuing its focus on process and supply chain improvements and cost reduction programs.

Risks identified include geopolitical situations and high tariffs. The promoters are contributing ₹49.5 crores through 7% NCRPS. The presentation was made to shareholders at the 66th Annual General Meeting held on September 2, 2026.